Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-29 Sale |
2023-03-30 5:53 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
139,950 | $36.31 | $5,081,111 | 1,556,949 (Indirect Direct) |
View |
| 2023-03-28 Sale |
2023-03-30 5:52 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
112,779 | $37.06 | $4,179,295 | 1,119,052 (Indirect Direct) |
View |
| 2023-02-23 Sale |
2023-02-27 7:14 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
25,000 | $37.27 | $931,658 | 1,231,831 (Indirect Direct) |
View |
| 2023-02-22 Sale |
2023-02-24 6:26 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $37.3 | $870,239 | 65,687 (Indirect Direct) |
View |
| 2002-12-12 Sale |
2022-12-13 6:20 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
60,000 | $42.01 | $2,520,623 | 196,899 (Indirect Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
84,302 | $43.15 | $3,637,463 | 33,547,592 (Indirect) |
View |
| 2022-12-01 Sale |
2022-12-05 4:44 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
362,766 | $44.04 | $15,974,737 | 11,406,894 (Indirect) |
View |
| 2022-11-21 Sale |
2022-11-22 5:29 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
40,000 | $43.14 | $1,725,567 | 1,126,831 (Indirect Direct) |
View |
| 2022-11-17 Sale |
2022-11-21 6:12 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
120,000 | $42.33 | $5,079,924 | 256,899 (Indirect Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 5:13 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
50,000 | $43.85 | $2,192,613 | 1,568,538 (Indirect Direct) |
View |
| 2022-11-08 Sale |
2022-11-10 5:04 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
24,500 | $43.47 | $1,065,013 | 990,390 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-04 7:16 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
5,500 | $43.06 | $236,846 | 1,014,890 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 4:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
100,000 | $41.23 | $4,122,670 | 1,324,700 (Indirect) |
View |
| 2022-09-28 Sale |
2022-09-30 4:15 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
32,593 | $41.05 | $1,337,943 | 33,994,660 (Indirect) |
View |
| 2022-09-22 Sale |
2022-09-26 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
211,380 | $41.17 | $8,702,113 | 34,027,253 (Indirect) |
View |
| 2022-09-20 Sale |
2022-09-22 4:31 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
523,842 | $41.07 | $21,516,554 | 11,848,633 (Indirect) |
View |
| 2022-09-20 Sale |
2022-09-22 4:30 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
267,815 | $41.02 | $10,985,798 | 21,426,170 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Director 10% Owner |
387,171 | $41.59 | $16,101,817 | 34,762,475 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 4:30 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
387,171 | $41.59 | $16,101,934 | 21,693,985 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 5:09 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. MGG Strategic SICAF SIF S.A. - MGG Strategic Director 10% Owner |
345,014 | $42.38 | $14,622,925 | 35,149,646 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 5:05 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. GG 1978 SICAF SIF S.A. - GG Strategic 10% Owner |
345,014 | $42.38 | $14,623,052 | 22,081,156 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-15 7:56 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
100,000 | $42.3 | $4,230,387 | 376,899 (Indirect Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 4:18 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
499,500 | $42.7 | $21,327,337 | 35,494,660 (Indirect) |
View |
| 2022-09-07 Sale |
2022-09-09 4:17 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
498,006 | $42.7 | $21,262,534 | 22,426,170 (Indirect) |
View |
| 2022-08-25 Sale |
2022-08-29 5:41 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
1,994 | $44 | $87,736 | 22,924,176 (Indirect) |
View |
| 2022-08-25 Sale |
2022-08-29 5:40 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
500 | $44 | $22,000 | 35,994,160 (Indirect) |
View |
| 2022-08-09 Sale |
2022-08-11 5:07 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
45,000 | $43.73 | $1,967,823 | 476,899 (Indirect Direct) |
View |
| 2022-08-09 Sale |
2022-08-11 5:02 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
20,854 | $43.92 | $915,909 | 1,357,945 (Indirect Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 7:12 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
30,000 | $43.19 | $1,295,727 | 1,020,390 (Indirect Direct) |
View |
| 2022-07-28 Sale |
2022-08-01 5:01 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
4,046 | $43.97 | $177,893 | 1,378,799 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-09 Conversion |
2023-05-12 6:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
330,000 | $0 | 2,211,008 (Direct) |
View |
| 2023-03-31 Option Award |
2023-03-31 4:40 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,049 | $35.73 | 87,236 (Direct) |
View |
| 2023-03-31 Option Award |
2023-03-31 4:38 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,049 | $35.73 | 34,830 (Direct) |
View |
| 2023-02-17 Conversion |
2023-02-17 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,650,000 | $0 | 2,080,958 (Direct) |
View |
| 2023-02-17 Conversion |
2023-02-17 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
77,000 | $0 | 217,614 (Direct) |
View |
| 2022-08-12 Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
150,640 | $0 | 5,709,377 (Indirect) |
View |
Ownership |
2023-02-10 7:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
0 | $0 | 5,709,377 (Indirect) |
View |
| 2022-12-30 Option Award |
2023-01-03 5:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
943 | $39.76 | 86,187 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 5:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
943 | $39.76 | 33,781 (Direct) |
View |
| 2022-08-12 Gift |
2022-11-14 5:13 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
5,889 | $0 | 1,568,538 (Direct) |
View |
| 2022-09-30 Option Award |
2022-09-30 4:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
913 | $41.06 | 32,838 (Direct) |
View |
| 2022-09-30 Option Award |
2022-09-30 4:25 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
913 | $41.06 | 85,244 (Direct) |
View |
| 2022-08-12 Gift |
2022-09-30 4:23 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
2,400 | $0 | 1,324,700 (Indirect) |
View |